{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:52:31Z","timestamp":1781481151811,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["OP ERDF of Comunitat Valenciana 2014-2020"],"award-info":[{"award-number":["OP ERDF of Comunitat Valenciana 2014-2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["OP ERDF of Comunitat Valenciana 2014-2020"],"award-info":[{"award-number":["OP ERDF of Comunitat Valenciana 2014-2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["OP ERDF of Comunitat Valenciana 2014-2020"],"award-info":[{"award-number":["OP ERDF of Comunitat Valenciana 2014-2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["OP ERDF of Comunitat Valenciana 2014-2020"],"award-info":[{"award-number":["OP ERDF of Comunitat Valenciana 2014-2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["OP ERDF of Comunitat Valenciana 2014-2020"],"award-info":[{"award-number":["OP ERDF of Comunitat Valenciana 2014-2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["OP ERDF of Comunitat Valenciana 2014-2020"],"award-info":[{"award-number":["OP ERDF of Comunitat Valenciana 2014-2020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2020-113839RB-I00"],"award-info":[{"award-number":["PID2020-113839RB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Conselleria de Educaci\u00f3n, Cultura y Universidades, Spain","award":["CIAICO\/2022\/190"],"award-info":[{"award-number":["CIAICO\/2022\/190"]}]},{"name":"VLC-Bioclinic","award":["PI-2023-004"],"award-info":[{"award-number":["PI-2023-004"]}]},{"name":"VLC-Biomed","award":["AP2024VLC-08"],"award-info":[{"award-number":["AP2024VLC-08"]}]},{"DOI":"10.13039\/100012619","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Fragilidad y Envejecimiento Saludable","doi-asserted-by":"publisher","award":["CB16\/10\/00435"],"award-info":[{"award-number":["CB16\/10\/00435"]}],"id":[{"id":"10.13039\/100012619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04882-0","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:06:57Z","timestamp":1777309617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peripheral blood biomarkers RCAN1, Clusterin, RAGE, and malondialdehyde for early diagnosis and progression of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Aurora","family":"Rom\u00e1n-Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mas-Bargues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Borr\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Vi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"4882_CR1","unstructured":"Dementia fact sheet https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"issue":"7","key":"4882_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, \u00d6hrfelt A, Portelius E, Bjerke M, et al. CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15(7):673\u201384.","journal-title":"Lancet Neurol"},{"issue":"4","key":"4882_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"4882_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12035-012-8237-1","volume":"45","author":"JT Yu","year":"2012","unstructured":"Yu JT, Tan L. The role of clusterin in Alzheimer\u2019s disease: pathways, pathogenesis, and therapy. Mol Neurobiol. 2012;45(2):314\u201326.","journal-title":"Mol Neurobiol"},{"issue":"7","key":"4882_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y, et al. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry. 2010;67(7):739\u201348.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"4882_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3233\/JAD-2011-110890","volume":"27","author":"A Lloret","year":"2011","unstructured":"Lloret A, Badia MC, Giraldo E, Ermak G, Alonso MD, Pallardo FV, et al. Amyloid-beta toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer\u2019s disease. J Alzheimers Dis. 2011;27(4):701\u20139.","journal-title":"J Alzheimers Dis"},{"issue":"48","key":"4882_CR7","first-page":"45450","volume":"278","author":"G Ermak","year":"2003","unstructured":"Ermak G, Davies KJA. RCAN1 (DSCR1 or Adapt78) stimulates expression of GSK-3\u03b2 and tau phosphorylation: implications for Alzheimer\u2019s disease. J Biol Chem. 2003;278(48):45450\u20137.","journal-title":"J Biol Chem"},{"issue":"7","key":"4882_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890","volume":"9","author":"R Deane","year":"2003","unstructured":"Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, et al. RAGE mediates amyloid-\u03b2 peptide transport across the blood\u2013brain barrier and accumulation in brain. Nat Med. 2003;9(7):907\u201313.","journal-title":"Nat Med"},{"issue":"3","key":"4882_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3233\/JAD-2012-121528","volume":"33","author":"N Lopez","year":"2013","unstructured":"Lopez N, Tormo C, De Blas I, Llinares I, Alom J. Oxidative stress in Alzheimer\u2019s disease and mild cognitive impairment with high sensitivity and specificity. J Alzheimers Dis. 2013;33(3):823\u20139.","journal-title":"J Alzheimers Dis"},{"key":"4882_CR10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.freeradbiomed.2021.05.009","volume":"171","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Wang Y, Tischfield M, Williams J, et al. Malondialdehyde as a biomarker for oxidative stress in mild cognitive impairment and Alzheimer\u2019s disease. Free Radic Biol Med. 2021;171:246\u201357.","journal-title":"Free Radic Biol Med"},{"key":"4882_CR11","first-page":"494","volume":"13","author":"P Monllor","year":"2017","unstructured":"Monllor P, Montell E, Reverter-Branchat G, et al. Blood-based biomarkers of oxidative stress and inflammation in Alzheimer\u2019s disease: a pilot study. Redox Biol. 2017;13:494\u2013501.","journal-title":"Redox Biol"},{"key":"4882_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fnagi.2015.00181","volume":"7","author":"J Olazar\u00e1n","year":"2015","unstructured":"Olazar\u00e1n J, Valent\u00ed M, Frades B, Zea-Sevilla MA, \u00c1vila-Villanueva M, Fern\u00e1ndez-Bl\u00e1zquez M\u00c1, et al. The vallecas project: a cohort to identify early markers and mechanisms of alzheimer\u2019s disease. Front Aging Neurosci. 2015;7:181.","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"4882_CR13","doi-asserted-by":"publisher","first-page":"e374","DOI":"10.1016\/S2666-7568(23)00079-X","volume":"4","author":"M Garo-Pascual","year":"2023","unstructured":"Garo-Pascual M, Gaser C, Zhang L, Tohka J, Medina M, Strange BA. Brain structure and phenotypic profile of superagers compared with age-matched older adults: a longitudinal analysis from the vallecas Project. Lancet Healthy Longev. 2023;4(8):e374\u2013e385.","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"4882_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/JAD-150956","volume":"52","author":"MA Fernandez-Blazquez","year":"2016","unstructured":"Fernandez-Blazquez MA, Avila-Villanueva M, Maestu F, Medina M. Specific features of subjective cognitive decline predict faster conversion to mild cognitive impairment. J Alzheimers Dis. 2016;52(1):271\u201381.","journal-title":"J Alzheimers Dis"},{"key":"4882_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.108941","volume":"709","author":"C Mas-Bargues","year":"2021","unstructured":"Mas-Bargues C, Escriva C, Dromant M, Borras C, Vina J. Lipid peroxidation as measured by chromatographic determination of malondialdehyde. human plasma reference values in health and disease. Arch Biochem Biophys. 2021;709:108941.","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"4882_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1567205012666150921101430","volume":"13","author":"A Lloret","year":"2016","unstructured":"Lloret A, Fuchsberger T, Giraldo E, Vina J. Reductive stress: a new concept in alzheimer\u2019s disease. Curr Alzheimer Res. 2016;13(2):206\u201311.","journal-title":"Curr Alzheimer Res"},{"key":"4882_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.freeradbiomed.2013.05.003","volume":"63","author":"MC Badia","year":"2013","unstructured":"Badia MC, Giraldo E, Dasi F, Alonso D, Lainez JM, Lloret A, et al. Reductive stress in young healthy individuals at risk of Alzheimer disease. Free Radic Biol Med. 2013;63:274\u20139.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"4882_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00109-009-0439-2","volume":"87","author":"SF Yan","year":"2009","unstructured":"Yan SF, Ramasamy R, Schmidt AM. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J Mol Med. 2009;87(3):235\u201347.","journal-title":"J Mol Med"},{"issue":"3","key":"4882_CR19","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3233\/JAD-201443","volume":"80","author":"P Monllor","year":"2021","unstructured":"Monllor P, Giraldo E, Badia MC, de la Asuncion JG, Alonso MD, Lloret A, et al. Serum levels of clusterin, PKR, and RAGE correlate with amyloid burden in alzheimer\u2019s disease. J Alzheimers Dis. 2021;80(3):1067\u201377.","journal-title":"J Alzheimers Dis"},{"issue":"47","key":"4882_CR20","doi-asserted-by":"publisher","first-page":"20021","DOI":"10.1073\/pnas.0905686106","volume":"106","author":"K Takuma","year":"2009","unstructured":"Takuma K, Fang F, Zhang W, Yan S, Fukuzaki E, Du H, et al. RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc Natl Acad Sci USA. 2009;106(47):20021\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"4882_CR21","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890","volume":"9","author":"R Deane","year":"2003","unstructured":"Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003;9(7):907\u201313.","journal-title":"Nat Med"},{"issue":"10","key":"4882_CR22","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","volume":"69","author":"JD Doecke","year":"2012","unstructured":"Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol. 2012;69(10):1318\u201325.","journal-title":"Arch Neurol"},{"issue":"13","key":"4882_CR23","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1001\/jama.2011.381","volume":"305","author":"EM Schrijvers","year":"2011","unstructured":"Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM. Plasma clusterin and the risk of Alzheimer disease. JAMA. 2011;305(13):1322\u20136.","journal-title":"JAMA"},{"key":"4882_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.dadm.2016.06.005","volume":"3","author":"G Weinstein","year":"2016","unstructured":"Weinstein G, Beiser AS, Preis SR, Courchesne P, Chouraki V, Levy D, et al. Plasma clusterin levels and risk of dementia, Alzheimer\u2019s disease, and stroke. Alzheimers Dement (Amst. 2016;3:103\u20139.","journal-title":"Alzheimers Dement (Amst"},{"issue":"11","key":"4882_CR25","doi-asserted-by":"publisher","first-page":"8074","DOI":"10.1002\/alz.14315","volume":"20","author":"SE Schindler","year":"2024","unstructured":"Schindler SE, Petersen KK, Saef B, Tosun D, Shaw LM, Zetterberg H, et al. Head-to-head comparison of leading blood tests for Alzheimer\u2019s disease pathology. Alzheimers Dement. 2024;20(11):8074\u201396.","journal-title":"Alzheimers Dement"},{"key":"4882_CR26","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1038\/s41591-025-03617-7","volume":"31","author":"K Horie","year":"2025","unstructured":"Horie K, Salvad\u00f3 G, Koppisetti RK, Janelidze S, Barth\u00e9lemy NR, He Y, et al. Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer\u2019s disease. Nat Med. 2025;31:2044\u20132053.","journal-title":"Nat Med"},{"issue":"6","key":"4882_CR27","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/s41591-025-03605-x","volume":"31","author":"G Grande","year":"2025","unstructured":"Grande G, Valletta M, Rizzuto D, Xia X, Qiu C, Orsini N, et al. Blood-based biomarkers of Alzheimer\u2019s disease and incident dementia in the community. Nat Med. 2025;31(6):2027\u201335.","journal-title":"Nat Med"},{"issue":"10","key":"4882_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20604","volume":"9","author":"X Zhang","year":"2023","unstructured":"Zhang X, Liu H, Huang Y, Wang R. A meta-analysis of neurogenic exosomes in the diagnosis of Alzheimer\u2019s disease. Heliyon. 2023;9(10):e20604.","journal-title":"Heliyon"},{"key":"4882_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.637218","volume":"13","author":"W Xing","year":"2021","unstructured":"Xing W, Gao W, Lv X, Xu X, Zhang Z, Yan J, et al. The diagnostic value of exosome-derived biomarkers in alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis. Front Aging Neurosci. 2021;13:637218.","journal-title":"Front Aging Neurosci"},{"key":"4882_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.936760","volume":"16","author":"Y Zou","year":"2022","unstructured":"Zou Y, Mu D, Ma X, Wang D, Zhong J, Gao J, et al. Review on the roles of specific cell-derived exosomes in Alzheimer\u2019s disease. Front Neurosci. 2022;16:936760.","journal-title":"Front Neurosci"},{"issue":"7","key":"4882_CR31","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3390\/biom11070980","volume":"11","author":"KY Kim","year":"2021","unstructured":"Kim KY, Shin KY, Chang KA. Brain-Derived exosomal proteins as effective biomarkers for alzheimer\u2019s disease: a systematic review and meta-analysis. Biomolecules. 2021;11(7):980.","journal-title":"Biomolecules"},{"issue":"3","key":"4882_CR32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/alz.12723","volume":"19","author":"C Tian","year":"2023","unstructured":"Tian C, Stewart T, Hong Z, Guo Z, Aro P, Soltys D, et al. Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer\u2019s disease. Alzheimers Dement. 2023;19(3):909\u201323.","journal-title":"Alzheimers Dement"},{"issue":"22","key":"4882_CR33","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1021\/acschemneuro.3c00641","volume":"14","author":"PK Mandal","year":"2023","unstructured":"Mandal PK, Maroon JC, Garg A, Arora NK, Bansal R, Kaushik A, et al. Blood biomarkers in alzheimer\u2019s disease. ACS Chem Neurosci. 2023;14(22):3975\u20133978.","journal-title":"ACS Chem Neurosci"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04882-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04882-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04882-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:04:07Z","timestamp":1781478247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04882-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4882"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04882-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were conducted in accordance with the ethical standards of the institutional and national research committees and with the 1964 Helsinki declaration and its later amendments. The study protocol was approved by the Ethics Committee of the institution responsible for the Vallecas Project (Reference ID: HIP CI CEI PI 46_2011-v2015). Written informed consent was obtained from all participants before inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"354"}}